Beacon Therapeutics’ AGTC-501 holds potential to become first gene therapy in XLRP space: GlobalData Read more
CRISPR-based innovations drive $21 bn in pharma licensing deals over five years: GlobalData Read more
Novartis and Voyager Therapeutics reach licence option agreement for next-generation gene therapy vectors for neurological diseases Read more
TSHA-102 from Taysha gets rare paediatric disease and orphan drug designations for Rett syndrome Read more